Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center

Yuichiro Shirai, Hidekata Yasuoka, Tsutomu Takeuchi, Toru Satoh, Masataka Kuwana

研究成果: Article査読

12 被引用数 (Scopus)

抄録

Objective: To assess the efficacy of epoprostenol treatment in Japanese patients with pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD). Methods: Sixteen patients with PAH-CTD treated with continuous intravenous epoprostenol at a single center between 2000 and 2009 were enrolled. Baseline characteristics, short-term and long-term outcomes, predictors of mortality, and safety profiles were evaluated. For survival analysis, 16 controls were selected who matched the underlying CTD, World Health Organization functional class, and use of PAH drugs, except for epoprostenol. Results: Six patients had systemic lupus erythematosus, five had mixed CTD, four had systemic sclerosis, and one had primary Sjögren's syndrome. The mean pulmonary arterial pressure (mPAP), cardiac index (CI), pulmonary vascular resistance, and functional class were significantly improved during the first 6 months of epoprostenol treatment. Cumulative survival rates at 1, 2, and 3 years in epoprostenol-treated patients were 69, 69, and 55 %, respectively, and were significantly better than those of the controls. Functional class, CI at baseline, and reduction of mPAP at 6 months were identified as predictors of survival. Adverse events, including flushing and catheterrelated infection, were frequent, but all patients tolerated the treatment. Conclusion: Based on the improvements in both shortterm and long-term outcomes among our patient cohort, epoprostenol is an effective treatment for CTD patients with advanced PAH.

本文言語English
ページ(範囲)1211-1220
ページ数10
ジャーナルModern Rheumatology
23
6
DOI
出版ステータスPublished - 01-11-2013
外部発表はい

All Science Journal Classification (ASJC) codes

  • Rheumatology

フィンガープリント 「Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル